Skip to main content
OpenTrials
Completed

NCT Number: NCT02336581

Researching the Effectiveness of Acceptance-Based Coping During Hospitalization

To test the effectiveness of Acceptance and Commitment Therapy (ACT) versus enhanced Treatment as Usual (eTAU) delivered by hospital staff for inpatients with psychotic-spectrum disorders.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Butler Hospital

Providence, Rhode Island, 02906, United States

About this study

Patients with psychotic disorders frequently require treatment at inpatient hospital settings during periods of acute illness for crisis management and stabilization. Although these patients often receive efficacious pharmacotherapy, there is a recognized lack of empirically-supported psychosocial interventions provided to patients in typical hospital settings. The provision of high quality psychosocial treatment during hospitalization is challenging due to short lengths of stay and a general lack of trained therapist employed on hospital units who can provide these evidence-based therapies. This unmet need for hospital psychosocial treatment represents a crucial missed opportunity to teach patients coping strategies that can speed time to recovery and impact post-discharge risk factors. Acceptance and Commitment Therapy (ACT) is a newer cognitive-behavioral approach that combines innovative mindfulness-based strategies for helping patients to cope more successfully with psychotic and other symptoms and implement values-consistent behavioral goals. However, adaptations to the original ACT approach are urgently needed to foster widespread implementation in community settings. The aim of the current study is to adapt the only promising acute-care psychosocial treatment for psychosis to be implementable in an inpatient setting and pilot test its effectiveness.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • current psychiatric hospitalization
  • diagnosis of schizophrenia, schizoaffective disorder, schizophreniform, brief psychotic disorder, delusional disorder, specified/unspecified other psychotic disorder, or a diagnosis of a mood disorder (major depressive disorder or bipolar disorder) with psychotic features, as determined by chart review and confirmed by the Structured Clinical Interview for Diagnostic and Statistical Manual (DSM)-5
  • 18 years or older
  • ability to speak and read English.

Exclusion criteria

  • psychosis severe enough to prevent participation in regular hospital groups
  • psychotic disorder related to a general medical condition or substance-induced psychotic disorder
  • significant cognitive impairment (mini-mental state exam score < 15).

Treatment and study plan

Acceptance and Commitment Therapy (ACT)

Behavioral

individual + group + follow-up phone contacts

Enhanced Treatment as Usual (ETAU)

Behavioral

individual + group + follow-up phone contacts

Primary outcomes

  1. Brief Psychiatric Rating Scale

    Time frame: Hospital Discharge (1 Week)

Secondary outcomes

  1. Psychiatric Rehospitalization

    Time frame: 4 Months Post-Discharge

Other outcomes

  1. Acceptance and Action Questionnaire-II

    Time frame: Hospital Discharge (1 Week)

Sponsors and collaborators

Lead sponsor

Butler Hospital

Other

Collaborators

  • National Institute of Mental Health (NIMH)

Registry information

Official study title

Effectiveness of Psychosocial Treatment for Inpatients With Psychosis

Acronym: REACH

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Jan 13, 2015
Registry last updated
Sep 20, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.